23.10.2012 Views

View PDF Version - RePub - Erasmus Universiteit Rotterdam

View PDF Version - RePub - Erasmus Universiteit Rotterdam

View PDF Version - RePub - Erasmus Universiteit Rotterdam

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Viral dynamics during tenofovir therapy 203<br />

Our data demonstrate that direct comparison of the effi cacies given by different mathematical<br />

models is not always possible. As we have demonstrated, variations between<br />

the models with respect to sampling frequencies and duration of follow up result in<br />

different outcomes. In addition, our data show that tenofovir is capable of effectively<br />

blocking viral replication in patients with lamivudine-induced mutant viruses in both HBV<br />

and HBV/ HIV co-infected patients. However, for effective treatment of patients, the first<br />

goal should be to totally inactivate disease by completely blocking virion production.<br />

In terms of modelling this will mean an antiviral effi cacy ‘ε’ equivalent to 1. Our results<br />

show that, in patients with lamivudine-induced drug-resistant mutants, we can reach an<br />

effi cacy of 0.99. Therefore, despite the drug having an excellent effect, our data also<br />

show some low-grade viral replication remains. We suggest that the residual replication<br />

may present a risk for genotypic succession during tenofovir therapy.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!